Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-268-9 | CAS number: 105-08-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
- Endpoint:
- endocrine system modulation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 4 days
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD Guideline 440 and GLPs.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Organisation for Economic Cooperation and Development (OECD) Guideline 440 for Testing of Chemicals- The Uterotrophic Bioassay in Rodents: A Short-term Screening Test for Oestrogenic Properties, 16 October 2007
- Deviations:
- no
- Principles of method if other than guideline:
- This study evaluated the ability of a mixture of 1,4-cyclohexanedimethanol (CHDM), 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD), and dimethyl terephthalate (DMT) to demonstrate or mimic biological activities consistent with agonism of natural estrogens. Animals received a combined dose of TMCD/CHDM in deionized water and then immediately a separate preparation of DMT in 0.5% methylcellulose. Both vehicles were prepared for administration to the control animals. Doses were administered per os to six groups of 10 ovariectomized female rats once daily for three consecutive days (Days 0-2). Dosage levels were 0 (solvent control), 0.001, 0.01, 0.1, 1, and 10 mg/kg bw/day, administered at a dosage volume of 5 mL/kg. The solvent control group received both vehicles at a dosage volume of 5 mL/kg . A positive control group composed of 10 ovariectomized females received 0.2 mg/kg bw/day of the estrogenic positive control agent 17α-Ethynylestradiol (EE) in corn oil on a comparable regimen, at a dosage volume of 10 mL/kg. Animals were observed for clinical signs and were weighed daily. Twenty-four hours after the last dose was administered, animals were euthanized, but no necropsies were conducted. The uteri were observed macroscopically, harvested, and wet and blotted uterine weights were recorded. The luminal fluid weight was calculated by subtracting the blotted uterine weight from the wet uterine weight. The uteri were preserved in 10% neutral buffered formalin for possible further microscopic evaluation.
- GLP compliance:
- yes
- Type of method:
- in vivo
- Endpoint addressed:
- toxicity to reproduction / fertility
Test material
- Reference substance name:
- Cyclohex-1,4-ylenedimethanol
- EC Number:
- 203-268-9
- EC Name:
- Cyclohex-1,4-ylenedimethanol
- Cas Number:
- 105-08-8
- Molecular formula:
- C8H16O2
- IUPAC Name:
- cyclohexane-1,4-diyldimethanol
- Reference substance name:
- [4-(hydroxymethyl)cyclohexyl]methanol
- IUPAC Name:
- [4-(hydroxymethyl)cyclohexyl]methanol
- Reference substance name:
- Cyclohexane-1,4-dimethanol; 1,4-Bis(hydroxymethyl)cyclohexane; CHDM
- IUPAC Name:
- Cyclohexane-1,4-dimethanol; 1,4-Bis(hydroxymethyl)cyclohexane; CHDM
- Details on test material:
- 1,4-Cyclohexanedimethanol (CHDM)
-Test material (as cited in report): 1,4-Cyclohexanedimethanol
-CAS number: 105-08-8
-Lot number: X30468-141
-Physical description: Clear, colorless liquid
-Purity: 99.87%
-Storage: Room temperature:
-Stability: Official stability studies were not conducted but the test substance is believed to be stable under the indicated conditions.
2,2,4,4-Tetramethyl-1,3-Cyclobutanediol (TMCD)
-Test material (as cited in report): 2,2,4,4-Tetramethyl-1,3-Cyclobutanediol
-CAS number: 3010-96-6
-Lot number: TS060513
-Physical description: White powder
-Purity: 100%
-Storage: Room temperature:
-Stability: Official stability studies were not conducted but the test substance is believed to be stable under the indicated conditions.
Dimethyl Terephthalate (DMT)
-Test material (as cited in report): Dimethyl Terephthalate
-CAS number: 120-61-6
-Lot number: X30468-142
-Physical description: White powder
-Purity: 99.98%
-Storage: Room temperature:
-Stability: Official stability studies were not conducted but the test substance is believed to be stable under the indicated conditions.
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Test animals:
-Source: Charles River Laboratories, Inc., Portage, MI
-Sex: ovariectomized female
-Age at receipt: approximately 50 days
-Age at study initiation: approximately 60 days
-Acclimation period: minimum of 11 days
-Weight at study initiation: 198-274 g
-Housing: individually housed in clean, stainless steel wire-mesh cages suspended above cage-board
-Diet: PMI Nutrition International, LLC, Certified Rodent LabDiet® 5002, ad libitum
-Water: reverse osmosis-purified, ad libitum
-Method of animal identification: unique Monel® metal ear tag
-Method of animal distribution: Computer program which randomized the animals based on stratification of body weights in a block design with individual body weights at randomization within ± 20% of the mean.
Environmental Conditions:
-Temperature: 21.3 - 21.4 °C
-Humidity: 35.5-42.9%
-Photoperiod: 12-hour light/12-hour dark photoperiod
-Air exchanges: 10 fresh air exchanges/hour
In-Life Study Dates:
-Study Initiation Date: August 5, 2008
-Experimental Start Date: August 15, 2008
-Experimental Completion Date: August 20, 2008
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Deionized water and methylcellulose for test substance and control; corn oil for positive control
- Details on exposure:
- 1,4-Cyclohexanedimethanol and 2,2,4,4-tetramethyl-1,3-cyclobutanediol were formulated together in deionized water while dimethyl terephthalate was prepared separately in 0.5% methyl cellulose. On each dosing day, each animal received a combined dose of 1,4-cyclohexanedimethanol and 2,2,4,4-tetramethyl-1,3-cyclobutanediol followed (within 1-2 minutes) by a separate dose of dimethyl terephthalate. Doses were prepared so that the test group received 0.001, 0.01, 0.1, 1, or 10 mg/kg bw/day of each test substance. The vehicle control group received separate daily doses of 0.5% methylcellulose and deionized water. The positive control, 17α-ethynylestradiol, was dissolved in a minimal amount of ethanol and then added to corn oil to achieve the appropriate dosing formulation. The vehicles, positive control, and test substance formulations were administered to their respective groups by oral gavage once daily for 3 consecutive days on study Days 0-2. The dosage volume was 5 mL/kg for the vehicle and test substance-treated groups and 10 mL/kg for the positive control substance-treated group. Individual dosages were based on the most recently recorded body weights to provide the correct mg/kg bw/day dose.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- TMCD/CHDM dosing formulations were solutions; therefore, homogeneity assessment was not required. Resuspension homogeneity and stability analyses of the DMT suspension and stability assessment of the TMCD/CHDM solution were conducted in a previous study at the same testing facility.
Quadruplicate samples (1.0 mL each) for homogeneity and concentration determinations were collected from the top, middle and bottom strata of the following:
-0, 0.2 and 2 mg/mL DMT dosing formulations and 0.05 mg/mL DMT stock solution on 13 August 2008; and
-0.0002, 0.002 and 0.02 mg/mL DMT dosing formulations on 15 August 2008.
Quadruplicate samples (1.0 mL each) for concentration determination were collected from:
-0, 0.0002, 0.002, 0.02, 0.2 and 2 mg/mL TMCD/CHDM dosing formulations and 0.05 mg/mL TMCD/CHDM stock solution on 13 August 2008.
Because initial analytical results were outside acceptable ranges, back-up samples collected from the 0.0002, 0.002 and 0.02 mg/mL DMT dosing formulations on 15 August 2008 were analyzed for concentration and homogeneity; initially processed samples were reanalyzed. Back-up samples collected from the 0.2 mg/mL TMCD/CHDM dosing formulation and the 0.05 mg/mL TMCD/CHDM stock formulation were also analyzed for concentration. All analyses were conducted by the Analytical Chemistry Department of WIL Research Laboratories, LLC using a validated high performance liquid chromatography method using ultraviolet absorbance detection. - Duration of treatment / exposure:
- On each of three consecutive dosing days, animals received a single dose of the 1,4-cyclohexanedimethanol/2,2,4,4-tetramethyl-1,3-cyclobutanediol formulation followed within 1-2 minutes by a single dose of dimethyl terephthalate.
- Frequency of treatment:
- daily for three days
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0.001 mg/kg bw/day TMCD/CHDM/DMT
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
0.01 mg/kg bw/day TMCD/CHDM/DMT
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
0.1 mg/kg bw/day TMCD/CHDM/DMT
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
1 mg/kg bw/day TMCD/CHDM/DMT
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
10 mg/kg bw/day TMCD/CHDM/DMT
Basis:
actual ingested
- No. of animals per sex per dose:
- 10 females/group
- Control animals:
- other: yes, concurrent vehicles
Examinations
- Examinations:
- Clinical Observations:
Animals were observed twice daily for moribundity and mortality. Detailed clinical observations were performed daily (prior to test substance administration) through the day of euthanasia. Animals were observed for signs of toxicity at the time of dosing (within 15 minutes) and one hour after dosing.
Body Weights:
Body weights were measured daily starting the day prior to dose administration to euthanasia.
Euthanasia:
Approximately 24 hours after the last dose, all surviving animals were euthanized with carbon dioxide.
Gross Necropsy:
Full necropsies were not performed. Macroscopic examination was limited to the uteri. The uterus (with luminal fluid) from each animal was harvested, trimmed, and weighed. Then the uterus was opened, blotted, and re-weighed. The uterus and vagina were fixed in 10% buffered neutral formalin for possible future histopathology. - Positive control:
- -Test substance: 17α-Ethynylestradiol (Sigma Aldrich, Inc., St. Louis, MO)
-Lot number: 107K1454
-Purity: 99.0%
-Physical description: white powder
Results and discussion
- Details on results:
- NOAEL: 10 mg/kg bw/day
Mortality: No mortality was observed during the study.
Clinical Abnormalities: There were no treatment-related clinical abnormalities noted during the study.
Body Weights: No test substance-related changes were noted in any TMCD/CHDM/DMT dose group. Statistically significant lower (p<0.01) body weights were observed in the positive control animals.
Macroscopic examination:
There were no test substance-related internal findings in the uterus at any dosage level. One female in the 0.001 mg/kg bw day TMCD/CHDM/DMT dose group was observed to have a small left uterine horn that also corresponded to lower wet and blotted uterine weights.
Organ Weights:
At all TMCD/CHDM/DMT dosage levels, there were no statistically significant differences from the vehicle control group. In the positive control group, mean wet and blotted uterine weights and calculated mean luminal fluid weight were significantly (p<0.01) higher compared to the vehicle control group.
Any other information on results incl. tables
Dosing Formulations:
Most of the analyzed dosing formulations were within acceptable ranges for concentrations and/or homogeneity based on the protocols used. In the absence of any test substance-related effects at any of the achieved dosage levels of dimethyl terephthalate, 1,3-cyclohexanedimethanol or 2,2,4,4-tetramethyl-1,3-cyclobutanediol, the out-of-specification results for the three lowest dimethyl terephthalate concentrations and a single intermediate 1,4-cyclohexanedimethanol concentration are not believed to affect the interpretation of the study results.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions used in this assay, 1,4-cyclohexanedimethanol (CHDM), 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD), and dimethyl terephthalate (DMT) when administered together did not demonstrate or mimic biological activities consistent with agonism of natural estrogens at dose levels up to 10 mg/kg bw/day. Based on the results observed when the three chemicals were administered together, it is reasonable to postulate that each chemical, if administered separately, would exhibit similar negative results.
Based on the results of this study, 1,4-cyclohexanedimethanol (CHDM), 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD), and dimethyl terephthalate (DMT) when administered together have a low potential to cause endocrine disruption, are not expected to cause adverse effects in developing females, and are not classified for “Developmental or Reproductive Toxicity” according to GHS. - Executive summary:
In a uterotrophic assay, 1,4-cyclohexanedimethanol (CHDM), 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD), and dimethyl terephthalate (DMT) were administered together by oral gavage to groups of 10 ovariectomized female Sprague-Dawley rats once daily at dose levels of 0, 0.001, 0.01, 0.1, 1, or 10 mg/kg bw/day for three consecutive days. A positive control group composed of 10 ovariectomized females received 0.2 mg/kg bw/day of 17α-Ethynylestradiol (EE) in corn oil on a comparable dosing regimen. No test substance-related adverse effects on clinical observations, mean body weights, uterine weights (wet and blotted) and calculated luminal fluid were noted in any dose group. Statistically significant lower (p<0.01) body weights and significantly higher (p<0.01) mean wet, blotted uterine weights and calculated mean luminal fluid weight were observed for the positive control group. Under the conditions of the study, 1,4-cyclohexanedimethanol (CHDM), 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD), and dimethyl terephthalate (DMT) did not demonstrate or mimic biological activities consistent with agonism of natural estrogens at dose levels up to 10 mg/kg bw/day. There is nothing in this study to suggest that any of the test materials, if administered separately, would cause endocrine disruption or reproductive/ developmental toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.